- Report
- May 2026
- 289 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 369 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 356 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 383 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 246 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,785GBP

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more